Biogen to cut 1000 more jobs by 2025

By Rebecca Trager2023-08-01T12:31:00

A sign saying Biogen with bikes locked nearby outside a modern office building

Source: © Tada Images/Shutterstock

Biotech giant has also agreed to buy Reata Pharmaceuticals for $7.3 billion

Biogen plans to lay off 1000 employees, over 11% of its global workforce, by 2025, as it reorganises to cut costs. The company already shed 900 staff worldwide in 2022, from about 9600 employees to 8700.